389
Views
5
CrossRef citations to date
0
Altmetric
Review

Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor

, ORCID Icon, &
Pages 491-503 | Received 11 Jan 2022, Accepted 11 Apr 2022, Published online: 26 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jiaqiang Wang, Hong Ge & Zhichao Tian. (2023) Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism?. OncoTargets and Therapy 16, pages 385-397.
Read now

Articles from other publishers (4)

Alicia A. Gingrich, Elise F. Nassif, Christina L. Roland & Emily Z. Keung. (2023) The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Current Oncology 30:2, pages 2144-2158.
Crossref
Areeba Saif, Emily A. Verbus, Amber Leila Sarvestani, Martha E. Teke, Jacob Lambdin, Jonathan M. Hernandez & David G. Kirsch. (2022) A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032). Annals of Surgical Oncology 30:2, pages 683-685.
Crossref
Binxiang Chu, Haihong Zheng, Xiaohe Zheng, Xingbing Feng & Zhenghua Hong. (2022) Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims. Frontiers in Cell and Developmental Biology 10.
Crossref
S. Bonvalot, C. Roland, C. Raut, C. Le Péchoux, D. Tzanis, A.M. Frezza & A. Gronchi. (2022) Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas. European Journal of Surgical Oncology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.